Anaerobes in diabetic foot infections: pathophysiology, epidemiology, virulence, and management
- PMID: 38819166
- PMCID: PMC11391693
- DOI: 10.1128/cmr.00143-23
Anaerobes in diabetic foot infections: pathophysiology, epidemiology, virulence, and management
Abstract
SUMMARYDiabetic foot infections (DFI) are a public health problem worldwide. DFI are polymicrobial, biofilm-associated infections involving complex bacterial communities organized in functional equivalent pathogroups, all including anaerobes. Indeed, multiple pathophysiological factors favor the growth of anaerobes in this context. However, the prevalence, role, and contribution of anaerobes in wound evolution remain poorly characterized due to their challenging detection. Studies based on culture reviewed herein showed a weighted average of 17% of patients with anaerobes. Comparatively, the weighted average of patients with anaerobes identified by 16S rRNA gene sequencing was 83.8%. Culture largely underestimated not only the presence but also the diversity of anaerobes compared with cultivation-independent approaches but both methods showed that anaerobic Gram-negative bacilli and Gram-positive cocci were the most commonly identified in DFI. Anaerobes were more present in deeper lesions, and their detection was associated with fever, malodorous lesions, and ulcer depth and duration. More specifically, initial abundance of Peptoniphilus spp. was associated with ulcer-impaired healing, Fusobacterium spp. detection was significantly correlated with the duration of DFI, and the presence of Bacteroides spp. was significantly associated with amputation. Antimicrobial resistance of anaerobes in DFI remains slightly studied and warrants more consideration in the context of increasing resistance of the most frequently identified anaerobes in DFI. The high rate of patients with DFI-involving anaerobes, the increased knowledge on the species identified, their virulence factors, and their potential role in wound evolution support recommendations combining debridement and antibiotic therapy effective on anaerobes in moderate and severe DFI.
Keywords: anaerobes; diabetic foot infection; diversity; epidemiology; management; pathophysiology; resistance; virulence.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
The role of anaerobes in diabetic foot infections.Anaerobe. 2015 Aug;34:8-13. doi: 10.1016/j.anaerobe.2015.03.009. Epub 2015 Apr 2. Anaerobe. 2015. PMID: 25841893 Review.
-
Prevalence of pathogens in diabetic foot infection in South Indian type 2 diabetic patients.J Assoc Physicians India. 2002 Aug;50:1013-6. J Assoc Physicians India. 2002. PMID: 12421021
-
Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents.J Clin Microbiol. 2007 Sep;45(9):2819-28. doi: 10.1128/JCM.00551-07. Epub 2007 Jul 3. J Clin Microbiol. 2007. PMID: 17609322 Free PMC article.
-
Microbiological profile and antimicrobial resistance among diabetic foot infections in Lebanon.Int Wound J. 2020 Dec;17(6):1764-1773. doi: 10.1111/iwj.13465. Epub 2020 Aug 11. Int Wound J. 2020. PMID: 32779355 Free PMC article.
-
The occurrence, virulence, and antimicrobial resistance of anaerobes in polymicrobial infections.Am J Surg. 1995 May;169(5A Suppl):2S-7S. Am J Surg. 1995. PMID: 7755163 Review.
Cited by
-
The healing process of diabetic ulcers correlates with changes in the cutaneous microbiota.Sci Rep. 2024 Nov 12;14(1):27628. doi: 10.1038/s41598-024-77987-2. Sci Rep. 2024. PMID: 39528566 Free PMC article.
-
New Strategies for the Treatment of Diabetic Foot Ulcers Using Nanoenzymes: Frontline Advances in Anti-Infection, Immune Regulation, and Microenvironment Improvement.Int J Nanomedicine. 2025 Jul 5;20:8783-8810. doi: 10.2147/IJN.S531396. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40635719 Free PMC article. Review.
-
Integrating bioinformatics and multiple machine learning to identify mitophagy-related targets for the diagnosis and treatment of diabetic foot ulcers: evidence from transcriptome analysis and drug docking.Front Mol Biosci. 2024 Jul 9;11:1420136. doi: 10.3389/fmolb.2024.1420136. eCollection 2024. Front Mol Biosci. 2024. PMID: 39044840 Free PMC article.
-
Innovations in hydrogel therapies for diabetic wound healing: bridging the gap between pathophysiology and clinical application.Burns Trauma. 2025 Apr 9;13:tkaf025. doi: 10.1093/burnst/tkaf025. eCollection 2025. Burns Trauma. 2025. PMID: 40740688 Free PMC article. Review.
References
-
- Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K, Edmonds M, Holstein P, Jirkovska A, Mauricio D, Ragnarson Tennvall G, Reike H, Spraul M, Uccioli L, Urbancic V, Van Acker K, van Baal J, van Merode F, Schaper N. 2007. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 50:18–25. doi:10.1007/s00125-006-0491-1 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous